Benitec Biopharma Ltd (BNTC)

[Blane]

Actually, Gilead has a number of challenges against Benitec.

Benitec's is one shot - eliminating compliance.

Benitec's is DDRNAi, not a traditional drug, which means virutally no side effects.

Benitec's is DDRNAi, which targets the Hep C virus on 3 different spots on the RNA, regardless of genotype - eliminating multiple regimens/drugs for different genotypes.

Benitec's is in-house developed, which means they could charge $20,000 per treatment, undercut Gilead with a far superior product, and still make massive bank...possibly, and very likely, owning the Hep C market worldwide. Since Gilead would have to charge out the nose for their treatments to recoup what they paid for Pharmaset.

Go Benitec!